DHS 145.08(14) (14) “Tuberculosis disease” means an illness determined by clinical or laboratory criteria or both to be caused by Mycobacterium tuberculosis.

DHS 145.08(15) (15) “Tuberculosis infection” means an infection with Mycobacterium tuberculosis in a person who has no symptoms of tuberculosis disease and is not infectious.

DHS 145.08 History History: Cr. Register, April, 1984, No. 340, eff. 5-1-84; r. and recr. Register, March, 2000, No. 531, eff. 4-1-00; CR 01-105: r. and recr. Register March 2002 No. 555, eff. 4-1-02.

DHS 145.09 DHS 145.09 Laboratory procedures.

DHS 145.09(1) (1) Any laboratory that receives a specimen for tuberculosis testing shall report all positive results as specified in s. DHS 145.04, including those obtained by an out-of-state laboratory, to the local health officer and to the department. The laboratory shall also submit an isolate from a patient with a positive culture to the state repository.

DHS 145.09 Note Note: Isolates for the state repository should be sent to: Mycobacteriology Laboratory, Wisconsin State Laboratory of Hygiene, 2601 Agriculture Dr., Room 254, Madison, WI 53718.

DHS 145.09(2) (2) Any laboratory that performs primary culture for mycobacteria shall perform organism identification using an approved rapid testing procedure specified in the official statement of the Association of Public Health Laboratories, unless specified otherwise by the state epidemiologist. The laboratory shall ensure at least 80% of culture-positive specimens are reported as either Mycobacterium tuberculosis complex or not Mycobacterium tuberculosis complex within 21 calendar days of the laboratory’s receipt of the specimens.

DHS 145.09 Note Note: The official statement of the Association of Public Health Laboratory entitled “Mycobacterium tuberculosis: assessing your laboratory”, 2013 is on file in the Legislative Reference Bureau, and is available from the Department’s Division of Public Health, P.O. Box 2659, Madison, WI 53701–2659..

DHS 145.09(3) (3) Any laboratory that identifies Mycobacterium tuberculosis shall ensure that antimicrobial drug susceptibility tests are performed on all initial isolates. The laboratory shall report the results of these tests to the local health officer or the department.

DHS 145.09 Note Note: Reports may be submitted to the Department’s Division of Public Health, P.O. Box 2659, Madison, WI 53701-2659.

DHS 145.09 History History: Cr. Register, April, 1984, No. 340, eff. 5-1-84; am. (1), Register, February, 1989, No. 398, eff. 3-1-89; r. and recr. Register, March, 2000, No. 531, eff. 4-1-00; CR 01-105: r. and recr. Register March 2002 No. 555, eff. 4-1-02.

DHS 145.10 DHS 145.10 Restriction and management of patients and contacts.

DHS 145.10(1) (1) All persons with infectious tuberculosis or suspected tuberculosis, and their contacts, shall exercise all reasonable precautions to prevent the infection of others, using the applicable methods of control set out in the official report of the American Public Health Association, unless specified otherwise by the state epidemiologist.

DHS 145.10 Note Note: The official report of the American Public Health Association entitled Control of Communicable Diseases Manual, 20th edition (2015), edited by David L. Heymann, is on file in the Department’s Division of Public Health and the Legislative Reference Bureau, and is available for purchase from the American Public Health Association, Publications Sales, PO Box 933019, Atlanta, GA 31193-3019.

DHS 145.10(2) (2) All persons with infectious tuberculosis or suspected tuberculosis shall be excluded from work, school and other premises that cannot be maintained in a manner adequate to protect others from being exposed to tuberculosis, as determined by the local health officer.

DHS 145.10(3) (3) Official statements of the American Thoracic Society shall be considered in the treatment of tuberculosis, unless specified otherwise by the state epidemiologist. Specific medical treatment shall be prescribed by a physician or other licensed prescriber.

DHS 145.10 Note Note: The official statements of the American Thoracic Society may be found in the Centers for Disease Control and Prevention’s recommendations and report “Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection.” The report may be found in the Morbidity and Mortality Weekly Report, June 9, 2000, Vol. 49, No. RR-6. The official statements of the American Thoracic Society, entitled “Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis” may be found in Clinical Infectious Diseases, vol. 63, 2016, pp. e147-e195. These reports are on file in the Legislative Reference Bureau, and are available from the Department’s Division of Public Health, P.O. Box 2659, Madison, WI 53701-2659.

DHS 145.10(4) (4) 

DHS 145.10(4)(a) (a) Any physician or licensed prescriber who treats a person with tuberculosis disease shall report all of the following to the local health officer:

DHS 145.10(4)(a)1. 1. The date of the person’s sputum conversion.

DHS 145.10(4)(a)2. 2. The date of the person’s completion of the tuberculosis treatment regimen.

DHS 145.10(4)(b) (b) The physician or his or her designee shall immediately report to the local health officer when a person with tuberculosis disease does any of the following:

DHS 145.10(4)(b)1. 1. Terminates treatment against medical advice.

DHS 145.10(4)(b)2. 2. Fails to comply with the medical treatment plan.

DHS 145.10(4)(b)3. 3. Fails to comply with measures to prevent transmission.

DHS 145.10(4)(b)4. 4. Leaves the hospital against the advice of a physician.

DHS 145.10(5) (5) Upon receiving a report under sub. (4) (b), the local health officer shall immediately investigate and transmit the report to the department.

DHS 145.10(6) (6) The local health officer or the department may do any of the following:

DHS 145.10(6)(a) (a) Order a medical evaluation of a person.